Our podcast is now available on all major platforms!
Spotify:
https://t.co/gtU0aquK39
YouTube: https://t.co/P4uZ2ni0cg
Apple Podcasts:
https://t.co/wfNL1ds33v
Podcast on Amazon music:
https://t.co/qSTHDlgY0s
Podcast on Audible:
https://t.co/ajujhYMYrK
Daily new episode!
They ditched the low-bid race to the bottom to focus on the one thing tech giants can't buy: time. Now 97% of revenue is negotiated, allowing them to arbitrage multiples while prepping $10B data centers. $CDNL https://t.co/HgvVPguBa7
The team that sold Dermira for 1.1 billion dollars went back to work two weeks later. They discovered our nerves and immune systems are talking behind our backs and they found a way to intercept the signal. $EVMN Listen: https://t.co/CUeINTvjal
The computer vision once used for Amazon Ring doorbells is now orchestrating autonomous drone swarms. Swarmer is building a vendor-agnostic OS to remove the human bottleneck and scale warfare like software. $SWMR https://t.co/EfRPX7NJ8X
@duvvurisriniva1 sorry, to keep costs in check, we are only covering cos with >1000cr mcap. Happy to discuss more if you'd like to sponsor some stories
Honeywell traded half its hardware unit to own the software middleware that runs on its rivals' machines. By solving error correction years early, they turned an industrial lab into the Cisco of quantum computing. $QNT https://t.co/SyioTXKGNV
After a 2016 scandal and death spiral, a legacy storage giant reinvented itself into the AI nervous system. While the world watches Nvidia, one company owns the light paths and custom silicon for hyperscalers. $MRVL https://t.co/Gza0ks9mpr
After a 2016 scandal and death spiral, a legacy storage giant reinvented itself into the AI nervous system. While the world watches Nvidia, one company owns the light paths and custom silicon for hyperscalers. $MRVL https://t.co/Gza0ks9mpr
Biofrontera jumped gross margins from 60% to 82% overnight by buying its freedom from its German parent. This micro-cap uses a razor-and-blade model to dethrone liquid nitrogen ahead of its 2026 catalyst. $BFRI https://t.co/TpyH5tb2r4
While rivals spent decades trying to block cancer's engine, MAIA fed it a poison pill the tumor weaves into its own DNA. This Trojan Horse tripled survival rates and holds the key to targeting 90% of all cancers. $MAIA https://t.co/6Sibly6q1E
Big Pharma left the platform for dead. OS Therapies picked it up for pennies, weaponized Listeria, and used a canine shortcut to end a 40-year drought in pediatric bone cancer. A masterclass in clinical arbitrage. $OSTX https://t.co/pJbmn5wD5w
Pancreatic tumors are biological fortresses that block blood and medicine. While Big Pharma hunts for new molecules, a lean team is pressure-washing tumors from the inside with proven, off-patent drugs. $RNXT https://t.co/eCR9SsHg4C